{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:03:19Z","timestamp":1761919399688},"reference-count":34,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,1,17]],"date-time":"2011-01-17T00:00:00Z","timestamp":1295222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Interphase fluorescent <jats:italic>in situ<\/jats:italic> hybridization (FISH) was applied on diagnostic BM smears from 519 children with acute lymphoblastic leukaemia (ALL) in order to establish the frequency and prognostic importance of 9p21 deletion in children enrolled in the Nordic Society of Paediatric Haematology and Oncology (NOPHO) \u2013 2000 treatment protocol. Among the patients, 452 were diagnosed with B\u2010cell precursor (BCP)\u2010ALL and 66 with T\u2010ALL. A higher incidence of 9p21 deletions was found in T\u2010ALL (38%) compared to BCP\u2010ALL (15\u00b77%). Homozygous deletions were found in 19\u00b77% of T\u2010ALL and 4\u00b70% of BCP\u2010ALL; hemizygous deletions were found in 18\u00b72% and 11\u00b77% respectively. In our series, 9p21 deletions were detected in all age groups with a steady rise in the frequency with age. There was no significant difference in outcome between cases with or without 9p21 deletion or between cases with hemi\u2010 or homozygous deletions of 9p21. In conclusion, in this large series of childhood ALL deletion of 9p21 was not associated with worse prognosis. However, interphase FISH deletion analysis of 9p21 could be used as a first step to detect unfavourable subtle cytogenetic aberrations such as the dic(9;20) rearrangement.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08532.x","type":"journal-article","created":{"date-parts":[[2011,1,18]],"date-time":"2011-01-18T03:42:25Z","timestamp":1295322145000},"page":"615-622","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Interphase fluorescent <i>in situ<\/i> hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO\u2010ALL 2000 protocol"],"prefix":"10.1111","volume":"152","author":[{"given":"Ekaterina","family":"Kuchinskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Nordgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"S\u00f6derh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peder","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Vettenranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olafur","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn","family":"Wesenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Sahl\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Nordenskj\u00f6ld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,17]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.8.3083.bloodjournal8883083"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.10188"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402697"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.2.572"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500513827"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.45"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(97)00007-6"},{"key":"e_1_2_5_9_1","first-page":"1855","article-title":"The prognostic significance of p16INK4a\/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia","volume":"5","author":"Faderl S.","year":"1999","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.10192"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20517"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.4002"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2352"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604130"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609054826"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-088310"},{"key":"e_1_2_5_17_1","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1182\/blood.V89.11.4161","article-title":"Homozygous deletion of the p16\/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome","volume":"89","author":"Kees U.R.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.04.006"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401124"},{"key":"e_1_2_5_20_1","first-page":"881","article-title":"The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B\u2010lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951","volume":"91","author":"Mirebeau D.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70066-8"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05690"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-100222"},{"key":"e_1_2_5_24_1","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood.V86.4.1548.bloodjournal8641548","article-title":"Loss of the cyclin\u2010dependent kinase 4\u2010inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies","volume":"86","author":"Ogawa S.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2008.04.003"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02586.x"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000109614"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.251"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-166801"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400817"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2007.00443.x"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2005.20.1.36"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.5.1778"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403769"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08532.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08532.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T13:19:38Z","timestamp":1697375978000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08532.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,17]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08532.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08532.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,17]]},"assertion":[{"value":"2011-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}